Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Treasury Shares: 2018-2025

Historic Treasury Shares for Aytu Biopharma (AYTU) over the last 8 years, with Sep 2025 value amounting to $31,294.

  • Aytu Biopharma's Treasury Shares rose 72.12% to $31,294 in Q3 2025 from the same period last year, while for Sep 2025 it was $31,294, marking a year-over-year increase of 72.12%. This contributed to the annual value of $32,912 for FY2025, which is 36.54% up from last year.
  • Latest data reveals that Aytu Biopharma reported Treasury Shares of $31,294 as of Q3 2025, which was down 4.92% from $32,912 recorded in Q2 2025.
  • Over the past 5 years, Aytu Biopharma's Treasury Shares peaked at $2.2 million during Q4 2021, and registered a low of $1,786 during Q1 2021.
  • For the 3-year period, Aytu Biopharma's Treasury Shares averaged around $33,770, with its median value being $34,528 (2025).
  • Per our database at Business Quant, Aytu Biopharma's Treasury Shares tumbled by 99.95% in 2021 and then surged by 119,579.79% in 2022.
  • Aytu Biopharma's Treasury Shares (Quarterly) stood at $2.2 million in 2021, then crashed by 98.00% to $43,276 in 2022, then decreased by 12.36% to $37,929 in 2023, then fell by 4.42% to $36,252 in 2024, then surged by 72.12% to $31,294 in 2025.
  • Its Treasury Shares was $31,294 in Q3 2025, compared to $32,912 in Q2 2025 and $34,528 in Q1 2025.